The right clinical trial tech stack isn’t the most complete one; it’s the one built with sites, funded fairly, and designed to remove friction, not add it.
- The Risks And Unresolved Rules Of Real-Time Clinical Trials
- What Real-Time Clinical Trials Demand From Your Tech Stack
- The FDA's RTCT Push: What It Is; Why It Matters
- Pharma's Digital Transformation: Where It's Really At
- How AI Is Changing Clinical Trial Design, Not Just Speed
- What Is Clinical Trials Day? Why Technology Helps Research Rise
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
- Why Are Life Science Companies So Poorly Prepared For RIM's Future?
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
A Checklist For Good TMF Health
The Trial Master File serves as the central repository of documentation. Utilize this guide to better concentrate on critical considerations and safeguard the well-being of your TMF.
-
Leveraging Empowered Patients To Build Better Clinical Registries
Uncover the potential of decentralized, patient-centric approaches in enhancing the efficiency and effectiveness of clinical trials and specifically, the creation of public or closed patient registries.
-
Is Your Legacy EDC Limiting AI's Impact On Your Clinical Data?
AI can enhance clinical data workflows, but aging EDC systems hold teams back. This piece breaks down key barriers and shows what’s needed to modernize data foundations for meaningful AI adoption.
-
Immuno-Inflammation Clinical Trials: Challenges And Solutions
Learn why having a strong and robust eCOA solution, along with an understanding of the specific challenges of this therapeutic area, is critical to the success of immuno-inflammation clinical trials.
-
Vendor Selection Bias: Why Structured Decisions Often Fail
Learn how subtle influences derail decisions and discover proven safeguards that promote transparency, accountability, and shared ownership for better trial outcomes.
-
Standardize Vaccine Study Launch Timelines To Just 5 Weeks
Uncover the pre-built vaccine trial solution that delivers quality and predictability for your entire immunology portfolio.
-
How To Make eConsent Accessible Across Diverse Populations
Accessible eConsent removes language, literacy, disability, and tech barriers, improving comprehension, equity, compliance, participant trust, inclusive enrollment, and data quality.
-
AI Won't Fix Clinical Development Until Pharma Changes How They Use It
Clinical development teams can unlock real AI value by aligning it to roles, workflows, and accountability. A practical operating model shows how to cut cycle time, reduce rework, and strengthen GxP‑ready decisions.
-
From Imaging To Analysis: 5 Steps For Success With TrialKit PACS
Obtain a fully integrated platform that seamlessly connects imaging data with EDC systems, resulting in streamlined data acquisition, real-time collaboration, and advanced analysis within a unified system.
-
Automation, Analytics, AI, And The Future Of Trial Monitoring
More teams are utilizing AI and automation to recruit and retain more patients. Discover how predictive analytics allow clinical trial teams to make better prognostications about patient behavior.
RECENT NEWSLETTERS
- 06.11.26 -- AI Governance, Site Tech Risk, And Trial Efficiency Gains
- 06.06.26 -- Best Of May: AI Risk, CRO Strategy, And Trial Cost Control
- 06.04.26 -- Why Clinical Execution — Not Tech — Is Trials' Biggest Risk
- 05.28.26 -- FDA's Elsa AI Shift, RTCT Rules, And RWE That Works
- 05.21.26 -- AI, HEOR, And Hidden Costs Reshaping Clinical Trials